Published in J Parasit Dis on February 16, 2011
Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria J (2004) 2.35
Some aspects of transmission of Wuchereria bancrofti and ecology of the vector Culex pipiens fatigans in Pondicherry. Indian J Med Res (1977) 1.10
Multicentre evaluations of two new rapid IgG4 tests (WB rapid and panLF rapid) for detection of lymphatic filariasis. Filaria J (2007) 1.10
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation (1994) 6.03
Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun (1985) 4.00
The economic burden of lymphatic filariasis in India. Parasitol Today (2000) 3.15
Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India. Trop Med Int Health (2000) 2.15
Mapping of lymphatic filariasis in India. Ann Trop Med Parasitol (2000) 2.00
Unusual association of Kikuchi's disease and dengue virus infection evolving into systemic lupus erythematosus. J Indian Med Assoc (2000) 1.96
Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest (1989) 1.74
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol (1992) 1.66
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis (2003) 1.65
Molecular discrimination inside polymer nanotubules. Nat Nanotechnol (2008) 1.62
Characterization of cultured tobacco cell lines resistant to ethionine, a methionine analog. Plant Physiol (1984) 1.57
Haematological and coagulation profile in acute falciparum malaria. J Assoc Physicians India (1992) 1.56
Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Trop Med Int Health (2001) 1.56
DDT indoor residual spray, still an effective tool to control Anopheles fluviatilis-transmitted Plasmodium falciparum malaria in India. Trop Med Int Health (2005) 1.54
Development and standardization of a rapid, PCR-based method for the detection of Wuchereria bancrofti in mosquitoes, for xenomonitoring the human prevalence of bancroftian filariasis. Ann Trop Med Parasitol (2002) 1.53
A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health (2000) 1.50
Transmission dynamics of diurnally subperiodic lymphatic filariasis transmitted by Ochlerotatus (Finlaya) niveus in the Andaman & Nicobar Islands. Indian J Med Res (2008) 1.45
Quantifying mosquito biting patterns on humans by DNA fingerprinting of bloodmeals. Am J Trop Med Hyg (2001) 1.44
IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol (1981) 1.40
Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol (1993) 1.35
Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol (1996) 1.35
Physical and psychosocial burden due to lymphatic filariasis as perceived by patients and medical experts. Trop Med Int Health (2005) 1.34
Value of butyrylthiocholine assay for identification of cholinesterase variants. J Med Genet (1970) 1.34
Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res (1989) 1.29
Bancroftian filariasis in Pondicherry, south India: 1. Pre-control epidemiological observations. Epidemiol Infect (1989) 1.29
Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet (1979) 1.28
EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect (2000) 1.27
A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage. Ann Trop Med Parasitol (2006) 1.26
Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol (1999) 1.25
A geostatistical analysis of the geographic distribution of lymphatic filariasis prevalence in southern India. Am J Trop Med Hyg (2002) 1.23
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Clinical manifestations in malayan filariasis infection with special reference to lymphoedema grading. Indian J Med Res (1990) 1.20
Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol (1993) 1.19
Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofti infection. Trans R Soc Trop Med Hyg (1990) 1.18
Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India. Trop Med Int Health (1999) 1.17
Detection of filaria-specific IgG4 antibodies using Brugia Rapid test in individuals from an area highly endemic for Brugia timori. Acta Trop (2004) 1.17
Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis. Ann Trop Med Parasitol (2005) 1.17
Multiple origins of the mtDNA 9-bp deletion in populations of South India. Am J Phys Anthropol (1999) 1.16
Subcellular distribution of monoclonal antibody defined epitopes on immunodominant Mycobacterium tuberculosis proteins in the 30-kDa region: identification and localization of 29/33-kDa doublet proteins on mycobacterial cell wall. Scand J Immunol (1991) 1.15
Functional impairment caused by lymphatic filariasis in rural areas of south India. Trop Med Int Health (1997) 1.14
T-cell receptor gamma delta bearing cells in normal human skin. J Invest Dermatol (1990) 1.13
Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol (2001) 1.13
The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Trop Med Int Health (2003) 1.11
Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. J Immunol Methods (1989) 1.10
Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol (1976) 1.10
The mosquito problem and type and costs of personal protection measures used in rural and urban communities in Pondicherry region, South India. Acta Trop (2003) 1.10
Population movement and malaria persistence in Rameswaram Island. Soc Sci Med (1986) 1.09
Estimation of the fecund life span of Wuchereria bancrofti in an endemic area. Trans R Soc Trop Med Hyg (1996) 1.09
Myocardial and haemodynamic effects of phentolamine. Br J Pharmacol (1971) 1.08
A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J Immunol (1993) 1.08
Comparison of effects of mass annual and biannual single dose therapy with diethylcarbamazine for the control of Malayan filariasis. Southeast Asian J Trop Med Public Health (1991) 1.07
Bancroftian filariasis in Pondicherry, south India: 2. Epidemiological evaluation of the effect of vector control. Epidemiol Infect (1989) 1.07
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface. Infect Immun (1992) 1.06
Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis (1998) 1.06
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
Isolation of a laminin-binding protein from the protozoan parasite Leishmania donovani that may mediate cell adhesion. Biochem J (1999) 1.04
Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am J Pathol (1992) 1.04
The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinquefasciatus: a study under natural conditions. Parasitology (1998) 1.04
Diversity and divergence among the tribal populations of India. Ann Hum Genet (2005) 1.04
The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology (2004) 1.03
Control of malaria and filariasis vectors in South India. Parasitol Today (1987) 1.03
The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Methods Inf Med (1998) 1.03
Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection. Ann Trop Med Parasitol (2009) 1.02
Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study. J Immunol (1997) 1.02
Extraosseous Ewing's sarcoma of the kidney. Urol Int (2002) 1.02
Larvicidal & synergestic activity of plant extracts for mosquito control. Indian J Med Res (1985) 1.02
Epifil: a dynamic model of infection and disease in lymphatic filariasis. Am J Trop Med Hyg (1998) 1.02
Fatal septicemic shock associated with Strongyloides stercoralis infection in a patient with angioimmunoblastic T-cell lymphoma: a case report and literature review. Parasitol Int (2012) 1.01
Skin-homing T lymphocytes: detection of cutaneous lymphocyte-associated antigen (CLA) by HECA-452 in normal human skin. Arch Dermatol Res (1993) 1.00
Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes. In Vitro Cell Dev Biol Anim (1997) 1.00
Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis (1997) 1.00
Seasonal abundance & biting behaviour of Mansonia annulifera, M. uniformis & M. indiana & their relative role in the transmission of malayan filariasis in Shertallai (Kerala state). Indian J Med Res (1991) 1.00
Parasitological aspects of malaria persistence in Koraput district Orissa, India. Indian J Med Res (1990) 0.99
Detection of filaria-specific IgG4 antibodies and filarial DNA, for the screening of blood spots for Brugia timori. Ann Trop Med Parasitol (2005) 0.98
Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis. Indian J Med Res (2000) 0.98
Pharmacological actions of Shilajit. Indian J Exp Biol (1988) 0.98
The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination. Trop Med Int Health (2002) 0.97
Microlevel epidemiological variations in malaria & its implications on control strategy. Indian J Med Res (1991) 0.97
Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis. Cochrane Database Syst Rev (2007) 0.97
Evidence of a laminin binding protein on the surface of Leishmania donovani. Biochem Biophys Res Commun (1996) 0.96
Preliminary findings from a cross-sectional study on lymphatic filariasis in children, in an area of India endemic for Brugia malayi infection. Ann Trop Med Parasitol (2007) 0.96
Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme. Trop Med Int Health (2009) 0.96
Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India. Ann Trop Med Parasitol (2005) 0.96
Phagocytosis by normal human melanocytes in vitro. Exp Cell Res (1993) 0.95
Localization of alpha-fetoprotein in human and rat fetal livers. An immunohistochemical method using horseradish peroxidase. J Histochem Cytochem (1974) 0.95
Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol (2006) 0.95
Operational feasibility of lot quality assurance sampling (LQAS) as a tool in routine process monitoring of filariasis control programmes. Trop Med Int Health (2006) 0.94
Type 1- and type 2-like lesional skin-derived Mycobacterium leprae-responsive T cell clones are characterized by coexpression of IFN-gamma/TNF-alpha and IL-4/IL-5/IL-13, respectively. J Immunol (1998) 0.94
Disappearing bone disease: a case report. Singapore Med J (1994) 0.94
Oxytocic activity of a pure phenolic glycoside (P2) from Saraca indica Linn (Ashoka): a short communication. Indian J Med Res (1970) 0.94
Endothelial cell marker PAL-E reactivity in brain tumor, developing brain, and brain disease. Cancer (1993) 0.94
Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India. Trans R Soc Trop Med Hyg (2011) 0.93
Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin. Arch Dermatol Res (1994) 0.93
PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim (2000) 0.93
Concentration and size dependence of nano-silver dispersed water based nanofluids. J Colloid Interface Sci (2012) 0.93